COMPOSITION INJECTION DEVICE
    2.
    发明公开

    公开(公告)号:US20240165340A1

    公开(公告)日:2024-05-23

    申请号:US18553107

    申请日:2021-03-29

    申请人: L&C BIO CO.,LTD.

    IPC分类号: A61M5/315

    CPC分类号: A61M5/31565

    摘要: A composition injection device includes a needle which is provided such that the ends of a distal part and proximal part thereof are open, and which is hollow such that a composition is injected thereto or discharged therefrom; a pressing member inserted into the needle to discharge the composition from the needle by pressurizing the composition injected into the needle; and a paddle which is formed to extend from the end of the distal part of the needle, and which enables the composition discharged from the needle to be applied, wherein the maximum width of the paddle is at most the outer diameter of the needle.

    ZAG-DERIVED PEPTIDE AND USE THEREOF
    5.
    发明申请

    公开(公告)号:US20200246428A1

    公开(公告)日:2020-08-06

    申请号:US16652045

    申请日:2018-09-28

    申请人: L&C Bio Co., LTD.

    摘要: The present invention relates to a zinc-alpha-2-glycoprotein (ZAG) protein-derived peptide and a use thereof. The ZAG protein-derived peptide according to the present invention shows an expression reducing effect of various immune factors shown in acute or chronic atopic dermatitis, and has a decreased immune response and decreased IgE expression and thus may be used to prevent, treat or improve xeroderma or an abnormal skin barrier function such as atopic dermatitis, an allergic disease or inflammation.